Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Drugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts say By: MarketWatch July 12, 2023 at 15:59 PM EDT Big pharma goes shopping as "patent cliff" puts more than $225 billion in revenues at risk. Read More >> Related Stocks: AbbVie Activision Blizzard Amgen Dice Therapeutics Inc Eli Lilly Horizon Therapeutics Microsoft Pfizer Seagen Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Drugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts say By: MarketWatch July 12, 2023 at 15:59 PM EDT Big pharma goes shopping as "patent cliff" puts more than $225 billion in revenues at risk. Read More >> Related Stocks: AbbVie Activision Blizzard Amgen Dice Therapeutics Inc Eli Lilly Horizon Therapeutics Microsoft Pfizer Seagen Inc